Frontiers in Pediatrics (Oct 2024)

Pediatric kidney transplantation in Europe, a clinical snapshot pilot

  • Loes Oomen,
  • Charlotte M. H. H. T. Bootsma-Robroeks,
  • Charlotte M. H. H. T. Bootsma-Robroeks,
  • Antonia H. M. Bouts,
  • Mar Carbonell Pradas,
  • Romy Gander,
  • Katrin Kienzl-Wagner,
  • Paul König,
  • Pedro Lopez Pereira,
  • Olivier Dunand,
  • Sara M. F. S. Mosca,
  • Michal Pac,
  • Ludmila Podracka,
  • Agnieszka A. Prytula,
  • Maria Sangermano,
  • Renata Vitkevic,
  • Jakub Zieg,
  • Loes F. M. van der Zanden,
  • Wout F. J. Feitz,
  • Liesbeth L. de Wall

DOI
https://doi.org/10.3389/fped.2024.1432027
Journal volume & issue
Vol. 12

Abstract

Read online

BackgroundPediatric kidney transplantations are rarely performed, and there is limited knowledge about the diversity in current clinical practices across Europe. This study aims to explore the utility of clinical snapshot studies in identifying these disparities, establishing a foundation for future snapshot studies and standardization efforts.MethodsA pilot clinical snapshot study was conducted, with invitations extended to all 109 pediatric kidney transplant centres in Europe. Each participating centre provided pre-, peri-, and postoperative data concerning their most recent thirty transplantations. The primary outcomes encompassed the evaluation of disparities in donor-recipient selection, surgical techniques, post-operative drainage procedures, and immunosuppressive therapy protocols. Secondary outcomes involved the analysis of rejection rates, incidence of infections, and graft survival.ResultsThe study involved 439 patients from fifteen centres (14%) in twelve countries, with varying transplant volumes (range 1–29 transplantations per year) and follow-up periods. Significant differences were found among centres in terms of donor types, cold and warm ischemia time, pre-emptive transplant rates, and kidney transplant drainage methods. The rate of living donors varied between 3% and 90% and the median duration of cold ischemia ranged was 770 min after deceased donation and 147 min after living donation. Basiliximab was the dominant induction therapy, yet steroid withdrawal varied widely. Infection, rejection, and graft survival rates also varied significantly between centres.ConclusionThis study revealed substantial variation in clinical practices among European centres performing pediatric kidney transplantations. These findings could serve as a stimulus for international dialogue and collaboration.

Keywords